[1/5] Chemist Zoe Sheaf prepares carbon suspension for bio catalytic hydrogenation at biotechnology research company HydRegen, based at University of Oxford Begbroke Science Park, in Kidlington near Oxford, Britain, June 16, 2023. REUTERS/Toby Melville OXFORD, England, June 20 (Reuters) - For Ros Deegan, the thrill of raising $100 million to expand a biotech firm among the dreaming spires of Oxford was soon tempered: unable to find a bigger laboratory, she routinely had to work at home. Not far away in the rival academic centre of Cambridge, biochemist Catherine Elton, persistently frustrated by similar real estate issues, taught herself how to...